top of page
The latest from NuvOx
Search
A Phase Ib/II clinical trial of DDFPe as a radiosensitizer in glioblastoma
Although small, this trial shows that DDFPe used as a radiosensitizer appears to be safe and may provide some survival benefit.
Nov 11, 2019
Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Trial
This randomized, placebo-controlled, double-blind, dose-escalation clinical trial in acute ischemic stroke patients was designed to...
Aug 28, 2019
Imaging assessment of cardioprotection mediated by DDFPe administered during myocardial infarction
DDFPe treatment in rats with myocardial infarction was associated by significantly reduced ischemia-reperfusion injury.
Mar 1, 2019
NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NanO2 (DDFPe) in the treatment of stroke have been published at the International Stroke Conference. A...
Feb 28, 2019
In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe)
DDFPe efficiently offloads oxygen to hypoxic environments. Link to publication
Jan 29, 2019
bottom of page